K.J. Harrison & Partners Inc Purchases 25 Shares of UnitedHealth Group Incorporated (NYSE:UNH)

K.J. Harrison & Partners Inc boosted its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 1.4% during the 4th quarter, HoldingsChannel.com reports. The fund owned 1,855 shares of the healthcare conglomerate’s stock after buying an additional 25 shares during the period. K.J. Harrison & Partners Inc’s holdings in UnitedHealth Group were worth $936,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also modified their holdings of the company. AlphaMark Advisors LLC purchased a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $30,000. RPg Family Wealth Advisory LLC bought a new position in UnitedHealth Group in the third quarter worth approximately $37,000. DecisionPoint Financial LLC grew its position in shares of UnitedHealth Group by 155.0% during the 4th quarter. DecisionPoint Financial LLC now owns 102 shares of the healthcare conglomerate’s stock valued at $52,000 after acquiring an additional 62 shares during the period. Highline Wealth Partners LLC bought a new position in UnitedHealth Group in the 3rd quarter worth $55,000. Finally, Legacy Investment Solutions LLC purchased a new stake in UnitedHealth Group in the third quarter worth about $57,000. Institutional investors own 87.86% of the company’s stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the stock. Stephens lifted their target price on shares of UnitedHealth Group from $605.00 to $675.00 and gave the company an “overweight” rating in a research note on Thursday, December 5th. KeyCorp reiterated an “overweight” rating and issued a $650.00 target price on shares of UnitedHealth Group in a research report on Friday, January 17th. Piper Sandler decreased their price objective on UnitedHealth Group from $605.00 to $600.00 and set an “overweight” rating on the stock in a report on Thursday, January 2nd. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 price objective for the company in a research note on Friday, January 10th. Finally, Truist Financial decreased their price objective on UnitedHealth Group from $625.00 to $610.00 and set a “buy” rating on the stock in a research report on Monday, January 6th. One equities research analyst has rated the stock with a hold rating, twenty have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, the stock presently has a consensus rating of “Buy” and an average target price of $629.32.

UnitedHealth Group Stock Down 1.4 %

UnitedHealth Group stock opened at $463.69 on Thursday. UnitedHealth Group Incorporated has a twelve month low of $436.38 and a twelve month high of $630.73. The business has a fifty day moving average of $517.50 and a two-hundred day moving average of $558.41. The firm has a market cap of $426.73 billion, a P/E ratio of 29.92, a P/E/G ratio of 1.37 and a beta of 0.61. The company has a quick ratio of 0.91, a current ratio of 0.83 and a debt-to-equity ratio of 0.74.

UnitedHealth Group (NYSE:UNH) last posted its earnings results on Thursday, January 16th. The healthcare conglomerate reported $6.81 earnings per share (EPS) for the quarter, beating the consensus estimate of $6.74 by $0.07. The company had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The firm’s quarterly revenue was up 6.8% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $5.83 earnings per share. On average, analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 18th. Stockholders of record on Monday, March 10th will be given a $2.10 dividend. The ex-dividend date of this dividend is Monday, March 10th. This represents a $8.40 dividend on an annualized basis and a dividend yield of 1.81%. UnitedHealth Group’s payout ratio is 54.19%.

Insider Buying and Selling at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,000 shares of the business’s stock in a transaction on Friday, January 17th. The shares were acquired at an average price of $511.57 per share, for a total transaction of $511,570.00. Following the purchase, the director now owns 4,500 shares of the company’s stock, valued at $2,302,065. This trade represents a 28.57 % increase in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. 0.33% of the stock is currently owned by company insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.